Why WebMD Is Poised to Pull Back
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, health-care website operator WebMD Health has received a dreaded one-star ranking.
With that in mind, let's take a closer look at WebMD and see what CAPS investors are saying about the stock right now.
Internet software and services
CEO Cavan Redmond (since 2012)
CFO Anthony Vuolo (since 2009)
Return on Equity (average, past 3 years)
$991.8 million / $800.0 million
Sources: S&P Capital IQ and Motley Fool CAPS.
On CAPS, 34% of the 174 members who have rated WebMD believe the stock will underperform the S&P 500 going forward.
A Faker Breaker that relies upon, rather than drives, its industry's growth. Ad business, with all attendant weaknesses (including required NYC positioning, and ad culture as opposed to purpose-driven culture). Tried to sell itself in 2011, unsuccessfully. Hated on Glassdoor. Recent run-up is likely an opportunity to sell. Underperform.
If you want market-topping returns, you need to protect your portfolio from any undue risk. Luckily, we've found another stock we are incredibly excited about -- excited enough to dub it "The Motley Fool's Top Stock for 2013." We have compiled a special free report for investors to uncover this stock today. The report is 100% free, but it won't be here forever, so click here to access it now.
Want to see how well (or not so well) the stocks in this series are performing? Follow the TrackPoisedTo CAPS account.
The article Why WebMD Is Poised to Pull Back originally appeared on Fool.com.Fool contributor Brian Pacampara has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.